These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8672287)
1. Eradication of rabies, using a rec-DNA vaccine. Terré J; Chappuis G; Lombard M; Desmettre P J Biotechnol; 1996 Apr; 46(2):156-7. PubMed ID: 8672287 [No Abstract] [Full Text] [Related]
2. Control of rabies in wildlife. Winkler WG; Bögel K Sci Am; 1992 Jun; 266(6):86-92. PubMed ID: 1585150 [No Abstract] [Full Text] [Related]
3. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
4. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production. Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z Virol J; 2011 Sep; 8():454. PubMed ID: 21943337 [TBL] [Abstract][Full Text] [Related]
5. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice. Kim HH; Yang DK; Nah JJ; Song JY; Cho IS Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885 [TBL] [Abstract][Full Text] [Related]
7. Human infection due to recombinant vaccinia-rabies glycoprotein virus. Rupprecht CE; Blass L; Smith K; Orciari LA; Niezgoda M; Whitfield SG; Gibbons RV; Guerra M; Hanlon CA N Engl J Med; 2001 Aug; 345(8):582-6. PubMed ID: 11529212 [No Abstract] [Full Text] [Related]
8. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236 [TBL] [Abstract][Full Text] [Related]
9. Plasmid vectors as anti-viral vaccines. Ertl HC; Verma P; He Z; Xiang ZQ Ann N Y Acad Sci; 1995 Nov; 772():77-87. PubMed ID: 8546415 [No Abstract] [Full Text] [Related]
10. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661 [TBL] [Abstract][Full Text] [Related]
11. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Ray NB; Ewalt LC; Lodmell DL Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541 [TBL] [Abstract][Full Text] [Related]
12. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325 [TBL] [Abstract][Full Text] [Related]
14. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector. Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345 [TBL] [Abstract][Full Text] [Related]
15. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies. Niu Y; Liu Y; Yang L; Qu H; Zhao J; Hu R; Li J; Liu W Virol Sin; 2016 Apr; 31(2):168-75. PubMed ID: 27068655 [TBL] [Abstract][Full Text] [Related]
17. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice. Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673 [TBL] [Abstract][Full Text] [Related]
18. Rabies vaccine development by expression of recombinant viral glycoprotein. Astray RM; Jorge SA; Pereira CA Arch Virol; 2017 Feb; 162(2):323-332. PubMed ID: 27796547 [TBL] [Abstract][Full Text] [Related]
19. A thermostable messenger RNA based vaccine against rabies. Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187 [TBL] [Abstract][Full Text] [Related]
20. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain]. Li W; Zhang Y; Wang S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]